Neutrogena unveils a new acne solution for adults, codesigned with leading dermatologists.
Published: 01 Apr 2026
Author: Precedence Research
Neutrogena, a leader in science-backed skincare, announces the launch of Evenly Clear. This product is specially designed to address adult acne by reducing breakouts, fading post-acne marks, and improving skin clarity. It is clinically proven to help restore and support the skin barrier, visibly reduce signs of hyperpigmentation, and address additional skincare concerns often experienced by adults with acne-prone skin.
Co-designed with dermatologists, the multi-benefit collection, such as skin concerns for adults under 40, addresses their post-acne mark concerns that are often driven by stress, hormones, and the pace of modern life.
Neutrogena Rolls Out Acne Solution
According to Towards Healthcare, the Adapalene market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 635.18 million in 2026 to approximately USD 899.37 million by 2035, representing a compound annual growth rate (CAGR) of 3.94% from 2026 to 2035. Growth is driven by rising acne prevalence globally, increasing dermatology awareness, growing demand for effective topical treatments, expanding over-the-counter availability, advancements in formulations, strong pharmaceutical marketing, and increasing skincare spending among adolescents and adults worldwide.
Acne isn't just a teen concern.
Acne is not just a teen problem; it can persist well into adulthood, even in your 30s, 40s, or beyond. To address this, the brand partnered with Global Innovation Partners Dr Dhaval Bhanusali and Dr Muneeb Shah, who recognise the unique skincare needs and routines of adults.
Joey King understands the challenges of treating acne as an adult. On the other side She appears with Dr. Bhanusali in the launch campaign, bringing fresh energy to the "adulting" conversation and reinforcing that confidence and care can evolve together.
Co-Designed with Dermatologists
Global Brand Lead for Neutrogena, Chris Riat, said that by engaging a community of leading dermatologists, and creating a clinically proven solution. With the story of Joey King, likewise, we can connect with consumers in an authentic, relatable way.
Dr. Bhanusali. Dr. Shah adds, by collaborating closely with Neutrogena®, we thoughtfully codesigned this collection, from sharing formula insights to recommending ingredients to consumers and providing valuable dermatological insights. We wanted to help in treating acne as an adult, easy to understand, and fit into busy routines.
A recent report by Towards Healthcare highlights that the Adapalene Market is expanding steadily, driven by rising acne prevalence, increasing dermatology awareness, growing skincare demand, and the availability of effective topical retinoid treatments worldwide.